Abstract
Osteogenesis imperfecta (OI) is a dominant skeletal disorder characterized by bone fragility and deformities. Though the oim mouse model has been the most widely studied of the OI models, it has only recently been suggested to exhibit gender-dependent differences in bone mineralization. To characterize the impact of gender on the morphometry/ultra-structure, mechanical properties, and biochemical composition of oim bone on the congenic C57BL/J6 background, 4-month-old oim/oim, +/oim, and wild-type (wt) female and male tibiae were evaluated using micro-computed tomography, three-point bending, and Raman spectroscopy. Dramatic gender differences were evident in both cortical and trabecular bone morphological and geometric parameters. Male mice had inherently more bone and increased moment of inertia than genotype-matched female counterparts with corresponding increases in bone biomechanical strength. The primary influence of gender was structure/geometry in bone growth and mechanical properties, whereas the mineral/matrix composition and hydroxyproline content of bone were influenced primarily by the oim collagen mutation. This study provides evidence of the importance of gender in the evaluation and interpretation of potential therapeutic strategies when using mouse models of OI.
Similar content being viewed by others
References
Bargman, R., A. Huang, A. L. Boskey, C. Raggio, and N. Pleshko. RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect. Tissue Res. 51:123–131, 2010.
Bargman, R., R. Posham, A. L. Boskey, E. Dicarlo, C. Raggio, and N. Pleshko. Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta. Osteoporos. Int. 23:1141–1150, 2012.
Camacho, N. P., P. Carroll, and C. L. Raggio. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice. Calcif. Tissue Int. 72:604–609, 2003.
Camacho, N. P., L. Hou, T. R. Toledano, W. A. Ilg, C. F. Brayton, C. L. Raggio, L. Root, and A. L. Boskey. The material basis for reduced mechanical properties in oim mice bones. J. Bone Miner. Res. 14:264–272, 1999.
Camacho, N. P., W. J. Landis, and A. L. Boskey. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy. Connect. Tissue Res. 35:259–265, 1996.
Camacho, N. P., C. L. Raggio, S. B. Doty, L. Root, V. Zraick, W. A. Ilg, T. R. Toledano, and A. L. Boskey. A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif. Tissue Int. 69:94–101, 2001.
Carleton, S. M., D. J. McBride, W. L. Carson, C. E. Huntington, K. L. Twenter, K. M. Rolwes, C. T. Winkelmann, J. S. Morris, J. F. Taylor, and C. L. Phillips. Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim). Bone 42:681–694, 2008.
Carleton, S. M., G. M. Whitford, and C. L. Phillips. Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathy. J. Nutr. 140:1752–1756, 2010.
Chipman, S. D., H. O. Sweet, D. J. McBride, Jr., M. T. Davisson, S. C. Marks, Jr., A. R. Shuldiner, R. J. Wenstrup, D. W. Rowe, and J. R. Shapiro. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc. Natl. Acad. Sci. U.S.A. 90:1701–1705, 1993.
Coleman, R. M., L. Aguilera, L. Quinones, L. Lukashova, C. Poirier, and A. Boskey. Comparison of bone tissue properties in mouse models with collagenous and non-collagenous genetic mutations using FTIRI. Bone 51:920–928, 2012.
Cundy, T. Recent advances in osteogenesis imperfecta. Calcif. Tissue Int. 90:439–449, 2012.
Delos, D., X. Yang, B. F. Ricciardi, E. R. Myers, M. P. Bostrom, and N. P. Camacho. The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta. J. Orthop. Res. 26:153–164, 2008.
Evans, K. D., S. T. Lau, A. M. Oberbauer, and R. B. Martin. Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta. Bone 32:268–274, 2003.
Forlino, A., W. A. Cabral, A. M. Barnes, and J. C. Marini. New perspectives on osteogenesis imperfecta. Nat. Rev. Endocrinol. 7:540–557, 2011.
Gentry, B. A., J. A. Ferreira, A. J. McCambridge, M. Brown, and C. L. Phillips. Skeletal muscle weakness in osteogenesis imperfecta mice. Matrix Biol. 29:638–644, 2010.
Guillot, P. V., O. Abass, J. H. Bassett, S. J. Shefelbine, G. Bou-Gharios, J. Chan, H. Kurata, G. R. Williams, J. Polak, and N. M. Fisk. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717–1725, 2008.
Hahn, M., M. Vogel, M. Pompesius-Kempa, and G. Delling. Trabecular bone pattern factor—a new parameter for simple quantification of bone microarchitecture. Bone 13:327–330, 1992.
Kamoun-Goldrat, A. S., and M. F. Le Merrer. Animal models of osteogenesis imperfecta and related syndromes. J. Bone Miner. Metab. 25:211–218, 2007.
Kim, B. T., L. Mosekilde, Y. Duan, X. Z. Zhang, L. Tornvig, J. S. Thomsen, and E. Seeman. The structural and hormonal basis of sex differences in peak appendicular bone strength in rats. J. Bone Miner. Res. 18:150–155, 2003.
Krabbe, S., C. Christiansen, P. Rodbro, and I. Transbol. Effect of puberty on rates of bone growth and mineralisation: with observations in male delayed puberty. Arch. Dis. Child. 54:950–953, 1979.
Lindberg, M. K., S. L. Alatalo, J. M. Halleen, S. Mohan, J. A. Gustafsson, and C. Ohlsson. Estrogen receptor specificity in the regulation of the skeleton in female mice. J. Endocrinol. 171:229–236, 2001.
Marini, J. C., A. Forlino, W. A. Cabral, A. M. Barnes, J. D. San Antonio, S. Milgrom, J. C. Hyland, J. Korkko, D. J. Prockop, A. De Paepe, P. Coucke, S. Symoens, F. H. Glorieux, P. J. Roughley, A. M. Lund, K. Kuurila-Svahn, H. Hartikka, D. H. Cohn, D. Krakow, M. Mottes, U. Schwarze, D. Chen, K. Yang, C. Kuslich, J. Troendle, R. Dalgleish, and P. H. Byers. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum. Mutat. 28:209–221, 2007.
Martin, R. B. Size, structure and gender: lessons about fracture risk. J. Musculoskelet. Neuronal Interact. 2:209–211, 2002.
McBride, Jr., D. J., J. R. Shapiro, and M. G. Dunn. Bone geometry and strength measurements in aging mice with the oim mutation. Calcif. Tissue Int. 62:172–176, 1998.
McCarthy, E. A., C. L. Raggio, M. D. Hossack, E. A. Miller, S. Jain, A. L. Boskey, and N. P. Camacho. Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr. Res. 52:660–670, 2002.
Mehrotra, M., M. Rosol, M. Ogawa, and A. C. Larue. Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies. Exp. Hematol. 38:593–602, 2010.
Miller, E., D. Delos, T. Baldini, T. M. Wright, and N. Pleshko Camacho. Abnormal mineral–matrix interactions are a significant contributor to fragility in oim/oim bone. J. Cell. Biochem. 81:206–214, 2007.
Misof, B. M., P. Roschger, T. Baldini, C. L. Raggio, V. Zraick, L. Root, A. L. Boskey, K. Klaushofer, P. Fratzl, and N. P. Camacho. Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone 36:150–158, 2005.
Olson, L. E., C. Ohlsson, and S. Mohan. The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice. Calcif. Tissue Int. 88:1–8, 2011.
Oz, O. K., J. E. Zerwekh, C. Fisher, K. Graves, L. Nanu, R. Millsaps, and E. R. Simpson. Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner. Res. 15:507–514, 2000.
Panaroni, C., R. Gioia, A. Lupi, R. Besio, S. A. Goldstein, J. Kreider, S. Leikin, J. C. Vera, E. L. Mertz, E. Perilli, F. Baruffaldi, I. Villa, A. Farina, M. Casasco, G. Cetta, A. Rossi, A. Frattini, J. C. Marini, P. Vezzoni, and A. Forlino. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114:459–468, 2009.
Pereira, R., J. S. Khillan, H. J. Helminen, E. L. Hume, and D. J. Prockop. Transgenic mice expressing a partially deleted gene for type I procollagen (COL1A1). A breeding line with a phenotype of spontaneous fractures and decreased bone collagen and mineral. J. Clin. Invest. 91:709–716, 1993.
Phillips, C. L., D. A. Bradley, C. L. Schlotzhauer, M. Bergfeld, C. Libreros-Minotta, L. R. Gawenis, J. S. Morris, L. L. Clarke, and L. S. Hillman. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone 27:219–226, 2000.
Primorac, D., D. W. Rowe, M. Mottes, I. Barisic, D. Anticevic, S. Mirandola, M. Gomez Lira, I. Kalajzic, V. Kusec, and F. H. Glorieux. Osteogenesis imperfecta at the beginning of bone and joint decade. Croat. Med. J. 42:393–415, 2001.
Rao, S. H., K. D. Evans, A. M. Oberbauer, and R. B. Martin. Bisphosphonate treatment in the oim mouse model alters bone modeling during growth. J. Biomech. 41:3371–3376, 2008.
Rauch, F., R. Travers, A. M. Parfitt, and F. H. Glorieux. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26:581–589, 2000.
Richman, C., S. Kutilek, N. Miyakoshi, A. K. Srivastava, W. G. Beamer, L. R. Donahue, C. J. Rosen, J. E. Wergedal, D. J. Baylink, and S. Mohan. Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice. J. Bone Miner. Res. 16:386–397, 2001.
Rosen, H. N., V. Chen, A. Cittadini, S. L. Greenspan, P. S. Douglas, A. C. Moses, and W. G. Beamer. Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density. J. Bone Miner. Res. 10:1352–1358, 1995.
Saban, J., M. A. Zussman, R. Havey, A. G. Patwardhan, G. B. Schneider, and D. King. Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Bone 19:575–579, 1996.
Saxon, L. K., G. Galea, L. Meakin, J. Price, and L. E. Lanyon. Estrogen receptors alpha and beta have different gender-dependent effects on the adaptive responses to load bearing in cancellous and cortical bone. Endocrinology 153:2254–2266, 2012.
Schriefer, J. L., A. G. Robling, S. J. Warden, A. J. Fournier, J. J. Mason, and C. H. Turner. A comparison of mechanical properties derived from multiple skeletal sites in mice. J. Biomech. 38:467–475, 2005.
Sillence, D. O., A. Senn, and D. M. Danks. Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 16:101–116, 1979.
Stegemann, H., and K. Stalder. Determination of hydroxyproline. Clin. Chim. Acta 18:267–273, 1967.
Vanleene, M., A. Porter, P. V. Guillot, A. Boyde, M. Oyen, and S. Shefelbine. Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice. Bone 50:1317–1323, 2012.
Vanleene, M., Z. Saldanha, K. L. Cloyd, G. Jell, G. Bou-Gharios, J. H. Bassett, G. R. Williams, N. M. Fisk, M. L. Oyen, M. M. Stevens, P. V. Guillot, and S. J. Shefelbine. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117:1053–1060, 2011.
Viguet-Carrin, S., P. Garnero, and P. D. Delmas. The role of collagen in bone strength. Osteoporos. Int. 17:319–336, 2006.
Wallace, J. M., R. M. Rajachar, X. D. Chen, S. Shi, M. R. Allen, S. A. Bloomfield, C. M. Les, P. G. Robey, M. F. Young, and D. H. Kohn. The mechanical phenotype of biglycan-deficient mice is bone- and gender-specific. Bone 39:106–116, 2006.
Acknowledgments
The authors gratefully thank Mark Dallas for assistance with μCT and three-point bending experiments. This work was supported by National Institutes of Health grant R01AR055907. This study utilized the Center for Research on Interfacial Structure and Properties (CRISP) and Center of Excellence in Mineralized Tissues (CEMT) facilities at the University of Missouri Kansas City.
Conflict of interest
The authors confirm they have full control of all primary data and will allow the journal to review the data. The authors confirm there is no conflict of interest or financial relationship with the organizations that sponsored this research.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Associate Editor Mona Kamal Marei oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Yao, X., Carleton, S.M., Kettle, A.D. et al. Gender-Dependence of Bone Structure and Properties in Adult Osteogenesis Imperfecta Murine Model. Ann Biomed Eng 41, 1139–1149 (2013). https://doi.org/10.1007/s10439-013-0793-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-013-0793-7